Published in Bull Soc Pathol Exot Filiales on November 01, 1983
Pregnancy and pregnancy-associated hormones alter immune responses and disease pathogenesis. Horm Behav (2012) 1.57
Estrogen and progesterone affect responses to malaria infection in female C57BL/6 mice. Gend Med (2008) 0.79
Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Mol Biochem Parasitol (2001) 3.49
Apathogenic, intestinal, segmented, filamentous bacteria stimulate the mucosal immune system of mice. Infect Immun (1993) 2.25
Clinical outcome of experimental human malaria induced by Plasmodium falciparum-infected mosquitoes. Neth J Med (2005) 2.10
Nitric oxide in cerebral malaria. J Infect Dis (1994) 1.64
Can Babesia infections be used as a model for cerebral malaria? Parasitol Today (1999) 1.53
Evaluation of the standard membrane feeding assay (SMFA) for the determination of malaria transmission-reducing activity using empirical data. Parasitology (2005) 1.44
Interactions between gut-associated lymphoid tissue and colonization levels of indigenous, segmented, filamentous bacteria in the small intestine of mice. Can J Microbiol (1998) 1.22
Oxidative stress in malaria; implications for prevention and therapy. Pharm World Sci (1996) 1.22
Immunological aspects of cerebral lesions in murine malaria. Clin Exp Immunol (1989) 1.16
Plasmodium berghei ANKA: purification of large numbers of infectious gametocytes. Exp Parasitol (1998) 1.15
Malaria chemosuppression in pregnancy. III. Its effects on the maternal malaria immunity. Trop Geogr Med (1993) 1.09
Plasmodium berghei: recombinant interferon-gamma and the development of parasitemia and cerebral lesions in malaria-infected mice. Exp Parasitol (1993) 1.07
Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparum. J Biol Chem (2001) 1.04
Pregnancy associated recrudescence in murine malaria (Plasmodium berghei). Tropenmed Parasitol (1980) 1.02
Low dosages of interleukin 1 protect mice against lethal cerebral malaria. J Exp Med (1990) 1.01
Morphological characteristics of intracerebral arterioles in clinical (Plasmodium falciparum) and experimental (Plasmodium berghei) cerebral malaria. J Neurol Sci (1991) 1.00
Convulsions due to increased permeability of the blood-brain barrier in experimental cerebral malaria can be prevented by splenectomy or anti-T cell treatment. J Infect Dis (1998) 1.00
Leukocytes in a Plasmodium falciparum-infected blood meal reduce transmission of malaria to Anopheles mosquitoes. Infect Immun (1997) 0.99
Depressed malarial immunity in pregnant mice. Infect Immun (1980) 0.97
In vitro development of infectious liver stages of P. yoelii and P. berghei malaria in human cell lines. Exp Parasitol (1994) 0.96
Dietary fish-oil supplementation in experimental gram-negative infection and in cerebral malaria in mice. J Infect Dis (1992) 0.94
Endomyocardial lesion and endomyocardial fibrosis in experimental malaria (Plasmodium berghei) in mice. Contrib Microbiol Immunol (1983) 0.91
Immunization against cerebral pathology in Plasmodium berghei-infected mice. Parasitology (1992) 0.91
Separation of parasitized erythrocytes from Plasmodium berghei infected mouse blood. Trans R Soc Trop Med Hyg (1977) 0.90
Cortisol and Plasmodium falciparum infection in pregnant women in Kenya. Trans R Soc Trop Med Hyg (1990) 0.89
Malaria immunity and premunition in a Plasmodium berghei mouse model. Isr J Med Sci (1978) 0.89
Circulating tumour necrosis factor alpha is not involved in the development of cerebral malaria in Plasmodium berghei-infected C57Bl mice. Parasite Immunol (1997) 0.88
Ultrastructural changes in the blood-brain barrier of mice infected with Plasmodium berghei. Acta Leiden (1992) 0.87
Cortisol and loss of malaria immunity in human pregnancy. Br J Obstet Gynaecol (1987) 0.87
Plasmodium berghei: effect of antithymocyte serum on induction of immunity in the mouse. Exp Parasitol (1979) 0.87
Chronic, patent Plasmodium berghei malaria in splenectomized mice. Infect Immun (1982) 0.87
Reduced adrenal response to bacterial lipopolysaccharide in interleukin-6-deficient mice. J Endocrinol Invest (2001) 0.86
Tumour necrosis factor-alpha and macrophages in Plasmodium berghei-induced cerebral malaria. Parasitology (1993) 0.86
Chloroquine containing liposomes in the chemotherapy of murine malaria. Parasitology (1989) 0.86
Immunological properties of recombinant proteins of the transmission blocking vaccine candidate, Pfs48/45, of the human malaria parasite Plasmodium falciparum produced in Escherichia coli. Parasite Immunol (1998) 0.85
Effects of interleukin-8 on nonspecific resistance to infection in neutropenic and normal mice. Antimicrob Agents Chemother (1993) 0.85
Role of spleen in morbidity and mortality of Plasmodium berghei infection in mice. Infect Immun (1980) 0.84
Roles of tumor necrosis factor alpha, granulocyte-macrophage colony-stimulating factor, platelet-activating factor, and arachidonic acid metabolites in interleukin-1-induced resistance to infection in neutropenic mice. Infect Immun (1994) 0.84
Dietary n-3 fatty acids increase spleen size and postendotoxin circulating TNF in mice; role of macrophages, macrophage precursors, and colony-stimulating factor-1. J Immunol (1996) 0.84
Role of macrophages in the pathogenesis of endomyocardial fibrosis in murine malaria. Trans R Soc Trop Med Hyg (1984) 0.84
Plasmodium berghei: premunition, sterile immunity, and loss of immunity in mice. Exp Parasitol (1980) 0.84
Induction of Plasmodium falciparum sporozoite-neutralizing antibodies upon vaccination with recombinant Pfs16 vaccinia virus and/or recombinant Pfs16 protein produced in yeast. Mol Biochem Parasitol (1995) 0.82
Therapeutic effect of chloroquine(CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasitized mouse red blood cells: comparison with combinations of antibodies and CQ or liposomal CQ. Biochim Biophys Acta (1989) 0.82
Protective and pathological activity in serum of mice developing resistance to Plasmodium berghei infection. Parasite Immunol (1989) 0.81
Selective damage of hippocampal neurons in murine cerebral malaria prevented by pentoxifylline. J Neurol Sci (1993) 0.81
Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice. J Pharmacol Exp Ther (1999) 0.81
Cortisol levels in human pregnancy in relation to parity and age. Am J Obstet Gynecol (1986) 0.80
Tissue reaction after intramuscular injection of liposomes in mice. Int J Clin Pharmacol Ther Toxicol (1992) 0.80
Pregnancy-induced recrudescences strengthen malarial immunity in mice infected with Plasmodium berghei. Parasitology (1985) 0.80
Histochemistry of cerebral lesions in mice infected with Plasmodium berghei. Trop Med Parasitol (1988) 0.80
Plasmodium vinckei: optimization of desferrioxamine B delivery in the treatment of murine malaria. Exp Parasitol (1998) 0.80
A cytochemical study of cerebrovascular lesions in mice infected with Plasmodium berghei. J Neurol Sci (1991) 0.80
The parenteral controlled release of liposome encapsulated chloroquine in mice. J Pharm Pharmacol (1990) 0.79
Plasmodium berghei: reduction of the mouse's specific lymphoproliferative response in relation to corticosterone and pregnancy. Exp Parasitol (1986) 0.79
Is malaria involved in the pathogenesis of tropical endomyocardial fibrosis? Acta Leiden (1988) 0.79
Malaria chemosuppression during pregnancy. IV. Its effects on the newborn's passive malaria immunity. Trop Geogr Med (1993) 0.79
Plasmodium falciparum: ribosomal P2 protein gene expression is independent of the developmentally regulated rRNAs. Exp Parasitol (1998) 0.79
Corticosterone regulation of the effector function of malarial immunity during pregnancy. Infect Immun (1982) 0.78
Myosin A expressions in sporogonic stages of Plasmodium. Mol Biochem Parasitol (2000) 0.78
Interleukin-1 (IL-1)-induced resistance to bacterial infection: role of the type I IL-1 receptor. Antimicrob Agents Chemother (1995) 0.77
Immune phagocytosis of Plasmodium berghei parasites by mononuclear phagocytes. Cell Biol Int Rep (1983) 0.77
Attenuation of malaria infection, paralysis and lesions in the central nervous system by low protein diets in rats. Acta Trop (1992) 0.77
Stage-specific proteins of Plasmodium berghei-infected red blood cells detected by antibodies of immune mouse serum. Parasitol Res (1988) 0.77
Malaria chemosuppression in pregnancy. V. Placenta malarial changes among three different prophylaxis groups. Trop Geogr Med (1993) 0.77
The need for live parasites for long-term immunity in malaria. Acta Leiden (1991) 0.77
The influence of the route of administration and liposome composition on the potential of liposomes to protect tissue against local toxicity of two antitumor drugs. Biochim Biophys Acta (1998) 0.76
Chloroquine blood levels after administration of the liposome-encapsulated drug in relation to therapy of murine malaria. Pharm Res (1989) 0.76
Relationship of the CD22 immunotoxin dose and the tumour establishment in a SCID mice model. Leuk Lymphoma (2000) 0.76
Impaired immune responsiveness in Plasmodium berghei immune mice. Parasite Immunol (1989) 0.76
Interleukin-1 as a possible agent for treatment of infection. Eur J Clin Microbiol Infect Dis (1993) 0.76
Treatment with recombinant human tumour necrosis factor-alpha reduces parasitaemia and prevents Plasmodium berghei K173-induced experimental cerebral malaria in mice. Parasitology (1999) 0.76
Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice. Antimicrob Agents Chemother (1999) 0.76
Activated macrophages: inductors of endocard lesions in murine malaria. Cell Biol Int Rep (1983) 0.76
Attenuated immunogenic parasites are essential in the transfer of immunity to virulent Plasmodium berghei. Immunology (1995) 0.75
Immunospecific targeting of liposomes to erythrocytes. Biochem Pharmacol (1988) 0.75
Interactions of Plasmodium berghei-infected erythrocytes with complement. J Protozool (1985) 0.75
Rodent malaria in rats exacerbated by milk protein, attenuated by low-protein vegetable diet. Trop Med Int Health (1998) 0.75
Pharmacokinetic and pharmacodynamic aspects of artelinic acid in rodents. J Pharm Pharmacol (1993) 0.75
ACTH-dependent modulation of malaria immunity in mice. Parasite Immunol (1985) 0.75
Plasmodium berghei: relative immunogenicity of infected reticulocytes and infected oxyphilic red blood cells. Exp Parasitol (1986) 0.75
Immunospecific targeting of immunoliposomes, F(ab')2 and IgG to red blood cells in vivo. Biochim Biophys Acta (1988) 0.75